Recall of proprietary Chinese medicine not complying with labelling and package insert requirements (with photo)

The Department of Health today (July 2) instructed American Oriental Bioengineering (Hong Kong) Limited to recall the product Jinji Capsule for not complying with the labelling and package insert requirements.